Vir Biotechnology (VIR) Non-Current Assets (2018 - 2026)

Vir Biotechnology (VIR) has 9 years of Non-Current Assets data on file, last reported at $502.6 million in Q1 2026.

• For the quarter ending Q1 2026, Non-Current Assets rose 33.84% year-over-year to $502.6 million; the trailing twelve-month figure through Mar 2026 stood at $1.9 billion (up 16.7% YoY), and the FY2025 full-year result was $488.7 million, up 37.15% from the prior year.
• Non-Current Assets advanced to $502.6 million in Q1 2026, from $488.7 million in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $580.9 million in Q1 2024 to a low of $275.7 million in Q3 2023.
• A 5-year average of $386.9 million and a median of $356.4 million in 2024 frame the typical range for Non-Current Assets.
• Across the five-year window, Non-Current Assets soared 124.31% in 2022 and tumbled 35.35% in 2025, its largest moves.
• Tracing VIR's Non-Current Assets over 5 years: stood at $283.0 million in 2022, then grew by 16.9% to $330.8 million in 2023, then advanced by 7.71% to $356.4 million in 2024, then surged by 37.15% to $488.7 million in 2025, then grew by 2.84% to $502.6 million in 2026.
• Business Quant data shows VIR's Non-Current Assets at $502.6 million in Q1 2026, $488.7 million in Q4 2025, and $473.8 million in Q3 2025.